Suppr超能文献

肌动蛋白细胞骨架作为预防甲基苯丙胺复吸的治疗靶点。

The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use.

作者信息

Young Erica J, Briggs Sherri B, Miller Courtney A

机构信息

130 Scripps Way, Jupiter, Florida 33458, USA.

出版信息

CNS Neurol Disord Drug Targets. 2015;14(6):731-7. doi: 10.2174/1871527314666150529145531.

Abstract

A high rate of relapse is a defining characteristic of substance use disorder for which few treatments are available. Exposure to environmental cues associated with previous drug use can elicit relapse by causing the involuntary retrieval of deeply engrained associative memories that trigger a strong motivation to seek out drugs. Our lab is focused on identifying and disrupting mechanisms that support these powerful consolidated memories, with the goal of developing therapeutics. A particularly promising mechanism is regulation of synaptic dynamics by actin polymerization within dendritic spines. Emerging evidence indicates that memory is supported by structural and functional plasticity dendritic spines, for which actin polymerization is critical, and that prior drug use increases both spine and actin dynamics. Indeed we have found that inhibiting amygdala (AMY) actin polymerization immediately or twenty-four hours prior to testing disrupted methamphetamine (METH)-associated memories, but not food reward or fear memories. Furthermore, METH training increased AMY spine density which was reversed by actin depolymerization treatment. Actin dynamics were also shifted to a more dynamic state by METH training. While promising, actin polymerization inhibitors are not a viable therapeutic, as a multitude of peripheral process (e.g. cardiac function) rely on dynamic actin. For this reason, we have shifted our focus upstream of actin polymerization to nonmuscle myosin II. We and others have demonstrated that myosin IIb imparts a mechanical force that triggers spine actin polymerization in response to synaptic stimulation. Similar to an actin depolymerizing compound, pre-test inhibition of myosin II ATPase activity in the AMY produced a rapid and lasting disruption of drug-seeking behavior. While many questions remain, these findings indicate that myosin II represents a potential therapeutic avenue to target the actin cytoskeleton and disrupt the powerful, extinction-resistant memories capable of triggering relapse.

摘要

高复发率是物质使用障碍的一个决定性特征,针对这一问题几乎没有可用的治疗方法。暴露于与先前药物使用相关的环境线索会引发复发,因为它会导致不由自主地唤起根深蒂固的联想记忆,从而引发强烈的寻求药物的动机。我们的实验室专注于识别和破坏支持这些强大巩固记忆的机制,目标是开发治疗方法。一种特别有前景的机制是通过树突棘内的肌动蛋白聚合来调节突触动力学。新出现的证据表明,记忆由树突棘的结构和功能可塑性支持,肌动蛋白聚合对此至关重要,并且先前的药物使用会增加树突棘和肌动蛋白的动力学。事实上,我们发现,在测试前立即或24小时抑制杏仁核(AMY)的肌动蛋白聚合会破坏与甲基苯丙胺(METH)相关的记忆,但不会破坏食物奖励或恐惧记忆。此外,METH训练增加了AMY的树突棘密度,而肌动蛋白解聚处理可使其逆转。METH训练还使肌动蛋白动力学转变为更动态的状态。虽然很有前景,但肌动蛋白聚合抑制剂不是一种可行的治疗方法,因为许多外周过程(如心脏功能)依赖于动态肌动蛋白。因此,我们将重点转移到肌动蛋白聚合上游的非肌肉肌球蛋白II。我们和其他人已经证明,肌球蛋白IIb会施加一种机械力,响应突触刺激触发树突棘肌动蛋白聚合。与肌动蛋白解聚化合物类似,在AMY中测试前抑制肌球蛋白II ATPase活性会迅速且持久地破坏觅药行为。虽然仍有许多问题,但这些发现表明,肌球蛋白II代表了一种潜在的治疗途径,可靶向肌动蛋白细胞骨架并破坏能够引发复发的强大的、抗消退的记忆。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc98/4641563/8d476e189006/nihms721748f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验